Ascidian Therapeutics | LinkedIn (original) (raw)

About us

Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA. By editing exons at the RNA level, Ascidian therapies enable precise post-transcriptional editing of genes, resulting in full-length, functional proteins at the right levels, in the right cells, at the right time. With active discovery and preclinical programs in ophthalmology, neurological and neuromuscular disorders, and other rare diseases, Ascidian is opening new therapeutic possibilities for patients in need of breakthroughs. For more information, visit www.ascidian-tx.com.

Industry

Biotechnology

Company size

11-50 employees

Headquarters

Boston, Massachusetts

Type

Privately Held

Founded

2020

Specialties

gene therapy, biotechnology, and RNA therapeutics

Locations

Employees at Ascidian Therapeutics

Updates

Missed the ‘Journey Through Vision Loss’ event at The Carroll Center for the Blind? You can still catch our #TeamAscidian presentation, 'Hope on the Horizon: ACDN-01 for Stargardt Disease.' Special thanks to Robert Bell, Alia Rashid, and Amber Trzeciak for their invaluable insights on: 🔆 Clinical Trials 🔆 #RNAExonEditing🔆 ACDN-01, our lead program targeting #StargardtDisease🔆 The #STELLARClinicalTrialWatch the recording 👉 https://lnkd.in/eA3shJPV and then learn more about ACDN-01 and the STELLAR trial here: https://bit.ly/4cmDjhO
Journey Through Vision Loss: ACDN-01 for Stargardt Disease - Ascidian Therapeutics

https://www.youtube.com/

#TeamAscidian is closing out #BlindnessAwarenessMonth by gearing up for the last segment of the 'Journey Through Vision Loss' event at The Carroll Center for the Blind this Saturday, November 2. Our own Robert Bell, Alia Rashid and Amber Trzeciak will be covering 'Hope on the Horizon: ACDN-01 for Stargardt Disease' by diving into: 💠 The ins and outs of clinical trials 👨🔬 💠 All things #RNAExonEditing ✨ 💠 ACDN-01, our lead program targeting #StargardtDisease 🚀 🔹 How it works 🔹 The study design and updates about our #STELLARClinicalTrialThe event will be recorded, so stay tuned! In the meantime, learn more about ACDN-01 and the STELLAR trial here: https://bit.ly/4cmDjhO and check out the event details below 👇

1,738 followers
1mo Edited
Join us Saturday, November 2 for "Journey Through Vision Loss", a unique in-person event designed to provide valuable insights, practical tools, and a supportive community for individuals experiencing vision loss, their families, and caregivers. - Learn about the latest advancements in Stargardt disease research from a leader in genetic research - Ascidian Therapeutics- Meet others who are navigating similar challenges and build a supportive network. - Participate in interactive hands-on workshops led by instructors from The Carroll Center for the Blind, each bringing a wealth of knowledge and practical expertise. Space is limited. Register today to save your seat $https://lnkd.in/e5AA\_HKg$ #VisionLoss #Stargardts #SeeWhatsPossible
Gwendolyn Wu and Ben Fidler of BioPharma Dive provide a state-of-play in the cutting-edge field of RNA editing. As our own Michael Ehlers explains, “It has all the features of a technology that could leapfrog other editing technologies.” Explore the evolution of RNA editing, the field’s latest breakthroughs, and how Ascidian's pioneering #RNAExonEditiors expand the possibilities of RNA medicines — making it possible to target “diseases caused by many different mutations rather than just one” 👉 https://lnkd.in/dnrJzgAi
For #WorldSightDay, we're celebrating Lucia and Sarafina, the “Stargardt Sisters” – who share an incredible bond in addition to a #StargardtDisease diagnosis. We’re immensely grateful to their mom, Sarah, for Zooming in with #TeamAscidian to share their story. It was a true pleasure to have you with us, Sarah. Hearing about Lucia, Sarafina, and your whole family of eight ignites our passion and reinforces why we do what we do. Thank you! Learn more about the ‘Stargardt Sisters’ and their family via the Foundation Fighting Blindness here: https://lnkd.in/eK4hA72G #ShareYourVision

Join now to see what you are missing

Join now